AGP Executive Report
Last update: 5 hours agoKidney drug deal for Vietnam: Dimerix’s Phase 3 rare kidney disease candidate DMX-200 has secured an exclusive licensing agreement with Everest Medicines, covering Greater China, South Korea and key Southeast Asian markets including Vietnam, with a US$10 million upfront payment and up to US$330 million in milestones plus 10–15% royalties. Food safety alert: Thailand’s FDA warned shops and consumers not to sell or eat 20 illegal or substandard food brands, urging immediate disposal and offering ways to check product serial numbers and report issues. Water pollution health risk in Mekong: An AFP report links illegal mining in Myanmar to spreading arsenic contamination in the Mekong basin, with doctors finding elevated arsenic levels in a Thai fisherman’s urine and fingernails and authorities reporting dangerous sediment levels near Chiang Saen. Maternal health & wellbeing via hospitality: Fusion Hotel Group and Hotel Management Japan announced a partnership to expand wellness-driven hospitality across Vietnam and the region, including cross-border staff training and brand design alignment. Public health access for migrants: South Korea plans 11-language web posters (including Vietnamese) to help migrant women affected by violence access protective services and hotlines regardless of immigration status.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
